Neurogene
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-925 | $0 |
Gross Profit | -812 | -762 | -798 | -812 |
EBITDA | -21,203 | -21,883 | -18,714 | -19,402 |
EBIT | -22,015 | -22,645 | -19,512 | -20,209 |
Net Income | -22,016 | -22,647 | -19,514 | -20,217 |
Net Change In Cash | 0 | 0 | -925 | 0 |
Free Cash Flow | -19,610 | -21,554 | -17,612 | -15,731 |
Cash | 58,813 | 70,771 | 136,586 | 66,633 |
Basic Shares | 21,055 | 20,996 | 14,854 | 16,953 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $925 | $0 | $0 | $0 |
Gross Profit | -2,322 | -3,262 | -3,196 | -2,277 |
EBITDA | -71,885 | -52,286 | -51,991 | -49,587 |
EBIT | -75,132 | -55,583 | -55,187 | -50,534 |
Net Income | -75,144 | -36,317 | -55,189 | -50,517 |
Net Change In Cash | 925 | 0 | 0 | 0 |
Free Cash Flow | -71,411 | -51,743 | -55,054 | -64,769 |
Cash | 136,586 | 148,210 | 82,021 | 70,544 |
Basic Shares | 17,567 | 12,823 | 12,823 | 55,041 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.05 |
2025-03-31 | -$1.08 |
2024-12-31 | -$0.99 |
2024-09-30 | -$1.19 |
